SecBot SecBot

SNGX

SOLIGENIX, INC.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0000812796 Biotech & Drug Discovery
$0.2900 −0.03 (−9.38%)
Nov 16 4:00 PM ET · prev $0.3200
Market cap
$7.4M
Nano cap
Median target
$1.38
+374% · range $1.25–1.50
1 year
−78.5%
from $1.35 · Nov 17
30 days
−14.7%
from $0.3400
52-week range
$0.2800–1.65
−82% from high · low May 11
Avg volume 20D
142.1K
Nov 16 spike 694.9K
Short interest
66.4K
≈0.3% of shares · −59.3%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/2

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q3 2026: 1 added (0 new), 2 trimmed or exited.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.070 → −$0.070 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersCOVERING

    Short interest −59.3% to 66.4K shares. 1.0 days to cover, ≈0.3% of shares.

  • TrendDOWNTREND

    19% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
JPMORGAN CHASE & CONEAR_EXIT1Not reported
JANE STREET GROUP, LLCTRIM62,709$22.7K
OSAIC HOLDINGS, INC.TRIM1Not reported
VANGUARD CAPITAL MANAGEMENT LLCADD81,005$32.1K
JONES FINANCIAL COMPANIES LLLPDOUBLED1,236$507.00
GEODE CAPITAL MANAGEMENT, LLCADD120,267$141.9K
UBS Group AGNEAR_EXIT2,346$2.8K
CITIGROUP INCNEAR_EXIT19$22.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Jul 2025
12-month targets · 2 analysts

Price is below the lowest target. Median implies +374%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Jul 16, 2025Alliance Global Partners
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 12, 2026
SCHABER CHRISTOPHER J
CHAIRMAN, CEO AND PRESIDENT
Oct 12, 2026
TO ISSUER583 sh
Oct 12, 2026
SCHABER CHRISTOPHER J
CHAIRMAN, CEO AND PRESIDENT
Oct 12, 2026
TO ISSUER197 sh
Oct 12, 2026
SCHABER CHRISTOPHER J
CHAIRMAN, CEO AND PRESIDENT
Oct 12, 2026
TO ISSUER250 sh
Oct 12, 2026
SCHABER CHRISTOPHER J
CHAIRMAN, CEO AND PRESIDENT
Oct 12, 2026
TO ISSUER52 sh
Oct 12, 2026
LAPOINTE ANTHONY GREGG
Director
Oct 12, 2026
TO ISSUER74 sh
Oct 12, 2026
RUBIN ROBERT J.
Director
Oct 12, 2026
TO ISSUER192 sh
Oct 12, 2026
ZELDIS JEROME B
Director
Oct 12, 2026
TO ISSUER54 sh
Oct 12, 2026
ZELDIS JEROME B
Director
Oct 12, 2026
TO ISSUER121 sh

Earnings setup

Estimates
−$0.07
EPS estimate, this quarter
0%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.07-$0.07–-$0.07+0.0%$0.00
Next Q-$0.07-$0.07–-$0.07+0.0%$0.00
Current FY-$0.40-$0.40–-$0.40+0.0%$0.00
Next FY-$0.25-$0.25–-$0.25+0.0%$0.00

Short side

FINRA· Oct 30, 2026
66,373
shares short
-59.3%
vs prior settlement
1.0
days to cover
≈0.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 6, 2026 SEC
Soligenix reported a net loss of $1.1M ($0.05 per share) for Q3 2026, narrower than the $2.5M loss in Q3 2025, driven…
PRESS-RELEASE · Impact 4/10
Nov 6, 2026 Earnings
Soligenix Announces Recent Updates and Third Quarter 2026 Financial Results
PRINCETON, N.J., Nov. 6, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compa
Nov 2, 2026 SEC
MJL Manager LLC, Michael Liu, and Capuchin Capital Fund LP filed an amended Schedule 13G disclosing a 9.4% passive…
SC 13G/A · Impact 2/10
Oct 12, 2026 Insider
SCHABER CHRISTOPHER J disposed of 583 shares
CHAIRMAN, CEO AND PRESIDENT
Oct 12, 2026 Insider
SCHABER CHRISTOPHER J disposed of 197 shares
CHAIRMAN, CEO AND PRESIDENT
Oct 12, 2026 Insider
SCHABER CHRISTOPHER J disposed of 250 shares
CHAIRMAN, CEO AND PRESIDENT
Sep 30, 2026 Inst.
JPMORGAN CHASE & CO · NEAR_EXIT
1 shares
Sep 30, 2026 Inst.
JANE STREET GROUP, LLC · TRIM
62,709 shares ($22.7K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
3 drugs tracked · Drug pipeline →
Recent

SecBot reports

7 filings · 0 bullish · 5 bearish · 2 neutral
All SNGX filing & press-release reports (7)